491 related articles for article (PubMed ID: 12115617)
1. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
[TBL] [Abstract][Full Text] [Related]
2. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
[TBL] [Abstract][Full Text] [Related]
3. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles.
Pasparakis M; Kousteni S; Peschon J; Kollias G
Cell Immunol; 2000 Apr; 201(1):33-41. PubMed ID: 10805971
[TBL] [Abstract][Full Text] [Related]
5. Involvement of distinct cellular compartments in the abnormal lymphoid organogenesis in lymphotoxin-alpha-deficient mice and alymphoplasia (aly) mice defined by the chimeric analysis.
Matsumoto M; Iwamasa K; Rennert PD; Yamada T; Suzuki R; Matsushima A; Okabe M; Fujita S; Yokoyama M
J Immunol; 1999 Aug; 163(3):1584-91. PubMed ID: 10415063
[TBL] [Abstract][Full Text] [Related]
6. Complementation of lymphotoxin alpha knockout mice with tumor necrosis factor-expressing transgenes rectifies defective splenic structure and function.
Alexopoulou L; Pasparakis M; Kollias G
J Exp Med; 1998 Aug; 188(4):745-54. PubMed ID: 9705956
[TBL] [Abstract][Full Text] [Related]
7. Expression of lymphotoxin beta governs immunity at two distinct levels.
Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
[TBL] [Abstract][Full Text] [Related]
8. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.
Prinz M; Montrasio F; Klein MA; Schwarz P; Priller J; Odermatt B; Pfeffer K; Aguzzi A
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):919-24. PubMed ID: 11792852
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
10. Lymphotoxin and LIGHT signaling pathways and target genes.
Schneider K; Potter KG; Ware CF
Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
[TBL] [Abstract][Full Text] [Related]
11. Priming of naive T cells inside tumors leads to eradication of established tumors.
Yu P; Lee Y; Liu W; Chin RK; Wang J; Wang Y; Schietinger A; Philip M; Schreiber H; Fu YX
Nat Immunol; 2004 Feb; 5(2):141-9. PubMed ID: 14704792
[TBL] [Abstract][Full Text] [Related]
12. Lymphotoxin-beta-deficient mice show defective antiviral immunity.
Berger DP; Naniche D; Crowley MT; Koni PA; Flavell RA; Oldstone MB
Virology; 1999 Jul; 260(1):136-47. PubMed ID: 10405365
[TBL] [Abstract][Full Text] [Related]
13. Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells.
Fletcher CA; Sutherland AP; Groom JR; Batten ML; Ng LG; Gommerman J; Mackay F
Eur J Immunol; 2006 Sep; 36(9):2504-14. PubMed ID: 16906535
[TBL] [Abstract][Full Text] [Related]
14. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis.
Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K
J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288
[TBL] [Abstract][Full Text] [Related]
16. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta.
Koni PA; Flavell RA
J Exp Med; 1998 Jun; 187(12):1977-83. PubMed ID: 9625757
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of graft arterial disease by manipulation of the LIGHT pathway.
Kosuge H; Suzuki J; Kakuta T; Haraguchi G; Koga N; Futamatsu H; Gotoh R; Inobe M; Isobe M; Uede T
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1409-15. PubMed ID: 15178556
[TBL] [Abstract][Full Text] [Related]
18. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
[TBL] [Abstract][Full Text] [Related]
19. Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.
Roach DR; Briscoe H; Saunders BM; Britton WJ
Infect Immun; 2005 Aug; 73(8):4787-92. PubMed ID: 16040991
[TBL] [Abstract][Full Text] [Related]
20. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.
Yu P; Wang Y; Chin RK; Martinez-Pomares L; Gordon S; Kosco-Vibois MH; Cyster J; Fu YX
J Immunol; 2002 May; 168(10):5117-23. PubMed ID: 11994465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
